Via the strain B/Yamagata from the influenza vaccine for the season 2026/2027. It has established the Ema, the European Agency of the drug, that has just published the updated recommendations on the composition of the seasonal vaccines. The decision, arrived after a long period of monitoring, is based on a well-established epidemiological data: the virus B/Yamagata has no longer been detected in circulation since March 2020. For this reason, the…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Via the strain B/Yamagata from the influenza vaccine for the season 2026/2027. It has established the Ema, the European Agency of the drug, that has just published the updated recommendations on the composition of the seasonal vaccines. The decision, arrived after a long period of monitoring, is based on a well-established epidemiological data: the virus B/Yamagata has no longer been detected in circulation since March 2020. For this reason, the…